Daten aus Post-Zulassungsstudie zu Impella RP auf der ACC 2019 präsentiert | Business Wire
Abiomed, Pfizer, Carvana, Uber, and More Market Movers
Stock of the Month: Abiomed, Inc. (ABMD) | Wolves Of Investing
Market Data - ABIOMED (NASD)
As Abiomed, Inc.'s (NASDAQ:ABMD)) market cap dropped by US$1.8b, insiders who sold US$6.3m worth of stock were able to offset their losses - Simply Wall St News
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio - December 22, 2022 - Zacks.com
Abiomed Stock Is Believed To Be Modestly Undervalued
Market Data - ABIOMED (NASD)
The Motley Fool Sits Down With Abiomed | The Motley Fool
Abiomed Shares Pop 50% on Johnson & Johnson Buyout
Market Data - ABIOMED (NASD)
Abiomed: Current Momentum Looks Sustainable After Year Of Controversy (NASDAQ:ABMD) | Seeking Alpha
Abiomed: Current Momentum Looks Sustainable After Year Of Controversy (NASDAQ:ABMD) | Seeking Alpha
Insulet Moves Up In Market Cap Rank, Passing ABIOMED
Abiomed Shares Pop 50% on John - GuruFocus.com
Abiomed (ABMD) - Market capitalization
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure | DAIC